Bill would give breakthrough medical devices four years of automatic Medicare coverage

Q: What does it cost, and who pays?

The bill provides $10 million per year from 2025 through 2030 to help Medicare implement these changes.

In markupH.R. 5343Latest action Sep 17, 2025

Sponsor: Blake D. Moore · Representative · UT

AIDecoded by AI · checked against the record

Read the official text

Official title: Ensuring Patient Access to Critical Breakthrough Products Act

119th Congress

Topics: Health care

Introduced: September 15, 2025

Read the official bill on Congress.gov

In plain words

The plain-language version comes first. The official text is always the reference.

The bill creates a four-year transitional period of automatic Medicare coverage for FDA-designated breakthrough devices.

40-second read · 5 questions answered below

What does this do?

This bill creates a four-year "transitional coverage period" during which Medicare automatically covers a device once it's designated an FDA "breakthrough device," if used as approved and safe. HHS must decide within 6 months whether a device qualifies, explaining any denial, and Medicare must finish any related national coverage decision before the four years end.

Who does it affect?

The bill affects Medicare patients, especially seniors and people with disabilities, medical device manufacturers, hospitals and doctors using these devices, and CMS, which administers Medicare.

Why does it matter?

The change would speed up patient access to new devices but adds new deadlines, funding needs, and oversight responsibilities for CMS, including monitoring billing for potential misuse.

What does it cost, and who pays?

$10 million per year
2025 through 2030
funds cms implementation

AI-drafted summary. Check it against the official text before you act on it.

Read the official bill on Congress.gov

Make the call

Three steps: where you stand, your script, the call.

Where do you stand?

Where does it stand?

IntroducedSep 15, 2025
House committeeYou are here · Sep 17, 2025
House vote
Senate
The president's desk

Right now: a House committee is reviewing it. If the Senate changes it, it goes back to the House before reaching the president.

Latest action: September 17, 2025 — Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.

See how a call works

Share on WhatsApp

How it's being covered

Coverage of this bill from across the press. Each outlet's political lean is labeled where AllSides has rated it, and marked "Not rated" where it has not.

Newest of these articles: Aug 10, 2026

medcitynews.com
Not rated
How CMS Is Tackling ‘Coverage Purgatory’ for Medical Devices
Aug 10, 2026
“CMS unveiled new details of its new RAPID pathway, which is designed to close the gap between FDA approval and Medicare coverage for breakthrough medical device...” — medcitynews.com
medicaldevice-network.com
Not rated
FDA and CMS outline new Medicare coverage pathway for medical device access
Apr 24, 2026
“The agencies’ initiative is intended to speed up the processes involved in medical devices’ securing Medicare coverage once approved by the FDA.” — medicaldevice-network.com
healthcaredive.com
Not rated
CMS, FDA unveil speedier Medicare coverage pathway for breakthrough devices
Apr 23, 2026
“The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class III breakthrough medical devices.” — healthcaredive.com
medpagetoday.com
Not rated
FDA, CMS to Launch Speedy Coverage Pathway for Breakthrough Medical Devices
Apr 23, 2026
“Eligible devices could be covered by Medicare as soon as 2 months after market authorization” — medpagetoday.com

Lean labels describe the news outlet, not this bill or any party. Ratings by AllSides.